India's Caplin Point gains on unit getting US FDA nod for generic heart disorder drug

Caplin Point Laboratories

05/02/2025 09:20

** Shares of Caplin Point Laboratories  CAPL.NS  climb ~5%
to 2,204.20 rupees
    ** Drugmaker's unit gets U.S. FDA nod for its copycat
version of heart disorder drug Pronestyl
    ** Drug used for treating patients with arrhythmia, which is
abnormal heart rhythm
    ** Stock gained ~84% in 2024 


 (Reporting by Kashish Tandon in Bengaluru)
 ((Kashish.tandon@thomsonreuters.com))